> top > projects > pubmed-enju-pas > docs > PubMed:30994353 > annotations
pubmed-enju-pas  

PubMed:30994353 JSONTXT 40 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
EnjuParser_T0 0-12 JJ denotes Quantitative
EnjuParser_T1 13-26 NN denotes Interrogation
EnjuParser_T2 27-29 IN denotes of
EnjuParser_T3 30-33 DT denotes the
EnjuParser_T4 34-39 NNP denotes Human
EnjuParser_T5 40-46 NNP denotes Kinome
EnjuParser_T6 47-56 NNP denotes Perturbed
EnjuParser_T7 57-59 IN denotes by
EnjuParser_T8 60-63 CD denotes Two
EnjuParser_T9 64-68 NN denotes BRAF
EnjuParser_T10 69-79 NNS denotes Inhibitors
EnjuParser_T11 81-90 JJ denotes Oncogenic
EnjuParser_T12 91-95 NN denotes BRAF
EnjuParser_T13 96-105 NNS denotes mutations
EnjuParser_T14 106-116 VBP denotes contribute
EnjuParser_T15 117-119 TO denotes to
EnjuParser_T16 120-123 DT denotes the
EnjuParser_T17 124-135 NN denotes development
EnjuParser_T18 136-138 IN denotes of
EnjuParser_T19 139-140 DT denotes a
EnjuParser_T20 141-147 NN denotes number
EnjuParser_T21 148-150 IN denotes of
EnjuParser_T22 151-158 NNS denotes cancers
EnjuParser_T23 158-159 -COMMA- denotes ,
EnjuParser_T24 160-163 CC denotes and
EnjuParser_T25 164-178 JJ denotes small-molecule
EnjuParser_T26 179-183 NN denotes BRAF
EnjuParser_T27 184-194 NNS denotes inhibitors
EnjuParser_T28 195-199 VBP denotes have
EnjuParser_T29 200-204 VBN denotes been
EnjuParser_T30 205-213 VBN denotes approved
EnjuParser_T31 214-216 IN denotes by
EnjuParser_T32 217-220 DT denotes the
EnjuParser_T33 221-225 NNP denotes Food
EnjuParser_T34 226-229 CC denotes and
EnjuParser_T35 230-234 NNP denotes Drug
EnjuParser_T36 235-249 NNP denotes Administration
EnjuParser_T37 250-251 -LRB- denotes (
EnjuParser_T38 251-254 NNP denotes FDA
EnjuParser_T39 254-255 -RRB- denotes )
EnjuParser_T40 256-259 IN denotes for
EnjuParser_T41 260-270 JJ denotes anticancer
EnjuParser_T42 271-278 NN denotes therapy
EnjuParser_T43 280-282 IN denotes In
EnjuParser_T44 283-287 DT denotes this
EnjuParser_T45 288-293 NN denotes study
EnjuParser_T46 293-294 -COMMA- denotes ,
EnjuParser_T47 295-297 PRP denotes we
EnjuParser_T48 298-306 VBD denotes employed
EnjuParser_T49 307-310 CD denotes two
EnjuParser_T50 311-319 VBN denotes targeted
EnjuParser_T51 320-332 JJ denotes quantitative
EnjuParser_T52 333-343 NNS denotes proteomics
EnjuParser_T53 344-354 NNS denotes approaches
EnjuParser_T54 355-358 IN denotes for
EnjuParser_T55 359-369 VBG denotes monitoring
EnjuParser_T56 370-380 RB denotes separately
EnjuParser_T57 381-384 DT denotes the
EnjuParser_T58 385-396 NNS denotes alterations
EnjuParser_T59 397-399 IN denotes in
EnjuParser_T60 400-407 NN denotes protein
EnjuParser_T61 408-418 NN denotes expression
EnjuParser_T62 419-422 CC denotes and
EnjuParser_T63 423-426 NN denotes ATP
EnjuParser_T64 427-434 NN denotes binding
EnjuParser_T65 435-445 NNS denotes affinities
EnjuParser_T66 446-448 IN denotes of
EnjuParser_T67 449-456 NNS denotes kinases
EnjuParser_T68 457-459 IN denotes in
EnjuParser_T69 460-468 VBN denotes cultured
EnjuParser_T70 469-474 JJ denotes human
EnjuParser_T71 475-483 NN denotes melanoma
EnjuParser_T72 484-489 NNS denotes cells
EnjuParser_T73 490-498 VBN denotes elicited
EnjuParser_T74 499-501 IN denotes by
EnjuParser_T75 502-505 CD denotes two
EnjuParser_T76 506-518 JJ denotes FDA-approved
EnjuParser_T77 519-533 JJ denotes small-molecule
EnjuParser_T78 534-538 NN denotes BRAF
EnjuParser_T79 539-549 NNS denotes inhibitors
EnjuParser_T80 549-550 -COMMA- denotes ,
EnjuParser_T81 551-561 NN denotes dabrafenib
EnjuParser_T82 562-565 CC denotes and
EnjuParser_T83 566-577 NN denotes vemurafenib
EnjuParser_T84 579-582 PRP-DOLLAR- denotes Our
EnjuParser_T85 583-590 NNS denotes results
EnjuParser_T86 591-597 VBD denotes showed
EnjuParser_T87 598-602 IN denotes that
EnjuParser_T88 603-612 NN denotes treatment
EnjuParser_T89 613-617 IN denotes with
EnjuParser_T90 618-621 DT denotes the
EnjuParser_T91 622-625 CD denotes two
EnjuParser_T92 626-636 NNS denotes inhibitors
EnjuParser_T93 637-640 VBD denotes led
EnjuParser_T94 641-643 TO denotes to
EnjuParser_T95 644-652 RB denotes markedly
EnjuParser_T96 653-662 JJ denotes different
EnjuParser_T97 663-675 NN denotes reprograming
EnjuParser_T98 676-678 IN denotes of
EnjuParser_T99 679-682 DT denotes the
EnjuParser_T100 683-688 JJ denotes human
EnjuParser_T101 689-695 NN denotes kinome
EnjuParser_T102 697-708 RB denotes Furthermore
EnjuParser_T103 708-709 -COMMA- denotes ,
EnjuParser_T104 710-712 PRP denotes we
EnjuParser_T105 713-722 VBD denotes confirmed
EnjuParser_T106 723-727 IN denotes that
EnjuParser_T107 728-739 NN denotes vemurafenib
EnjuParser_T108 740-745 MD denotes could
EnjuParser_T109 746-756 VB denotes compromise
EnjuParser_T110 757-760 DT denotes the
EnjuParser_T111 761-764 NN denotes ATP
EnjuParser_T112 765-772 NN denotes binding
EnjuParser_T113 773-781 NN denotes capacity
EnjuParser_T114 782-784 IN denotes of
EnjuParser_T115 785-791 NN denotes MAP2K5
EnjuParser_T116 792-794 FW denotes in
EnjuParser_T117 795-800 FW denotes vitro
EnjuParser_T118 801-804 CC denotes and
EnjuParser_T119 805-812 VB denotes inhibit
EnjuParser_T120 813-816 PRP-DOLLAR- denotes its
EnjuParser_T121 817-823 NN denotes kinase
EnjuParser_T122 824-832 NN denotes activity
EnjuParser_T123 833-835 IN denotes in
EnjuParser_T124 836-841 NNS denotes cells
EnjuParser_T125 843-851 RB denotes Together
EnjuParser_T126 851-852 -COMMA- denotes ,
EnjuParser_T127 853-856 PRP-DOLLAR- denotes our
EnjuParser_T128 857-865 VBN denotes targeted
EnjuParser_T129 866-878 JJ denotes quantitative
EnjuParser_T130 879-888 JJ denotes proteomic
EnjuParser_T131 889-896 NNS denotes methods
EnjuParser_T132 897-905 VBD denotes revealed
EnjuParser_T133 906-914 JJ denotes profound
EnjuParser_T134 915-922 NNS denotes changes
EnjuParser_T135 923-925 IN denotes in
EnjuParser_T136 926-936 NN denotes expression
EnjuParser_T137 937-943 NNS denotes levels
EnjuParser_T138 944-946 IN denotes of
EnjuParser_T139 947-953 NN denotes kinase
EnjuParser_T140 954-962 NNS denotes proteins
EnjuParser_T141 963-965 IN denotes in
EnjuParser_T142 966-974 VBN denotes cultured
EnjuParser_T143 975-983 NN denotes melanoma
EnjuParser_T144 984-989 NNS denotes cells
EnjuParser_T145 990-994 IN denotes upon
EnjuParser_T146 995-1004 NN denotes treatment
EnjuParser_T147 1005-1009 IN denotes with
EnjuParser_T148 1010-1020 RB denotes clinically
EnjuParser_T149 1021-1025 VBN denotes used
EnjuParser_T150 1026-1030 NN denotes BRAF
EnjuParser_T151 1031-1041 NNS denotes inhibitors
EnjuParser_T152 1042-1045 CC denotes and
EnjuParser_T153 1046-1049 VBD denotes led
EnjuParser_T154 1050-1052 TO denotes to
EnjuParser_T155 1053-1056 DT denotes the
EnjuParser_T156 1057-1066 NN denotes discovery
EnjuParser_T157 1067-1069 IN denotes of
EnjuParser_T158 1070-1075 JJ denotes novel
EnjuParser_T159 1076-1084 JJ denotes putative
EnjuParser_T160 1085-1091 NN denotes target
EnjuParser_T161 1092-1099 NNS denotes kinases
EnjuParser_T162 1100-1103 IN denotes for
EnjuParser_T163 1104-1109 DT denotes these
EnjuParser_T164 1110-1120 NNS denotes inhibitors
EnjuParser_R0 EnjuParser_T1 EnjuParser_T0 arg1Of Interrogation,Quantitative
EnjuParser_R1 EnjuParser_T1 EnjuParser_T2 arg1Of Interrogation,of
EnjuParser_R10 EnjuParser_T13 EnjuParser_T11 arg1Of mutations,Oncogenic
EnjuParser_R100 EnjuParser_T105 EnjuParser_T102 arg1Of confirmed,Furthermore
EnjuParser_R101 EnjuParser_T105 EnjuParser_T103 arg1Of confirmed,","
EnjuParser_R102 EnjuParser_T104 EnjuParser_T105 arg1Of we,confirmed
EnjuParser_R103 EnjuParser_T118 EnjuParser_T105 arg2Of and,confirmed
EnjuParser_R104 EnjuParser_T118 EnjuParser_T106 arg1Of and,that
EnjuParser_R105 EnjuParser_T107 EnjuParser_T108 arg1Of vemurafenib,could
EnjuParser_R106 EnjuParser_T118 EnjuParser_T108 arg2Of and,could
EnjuParser_R107 EnjuParser_T107 EnjuParser_T109 arg1Of vemurafenib,compromise
EnjuParser_R108 EnjuParser_T113 EnjuParser_T109 arg2Of capacity,compromise
EnjuParser_R109 EnjuParser_T113 EnjuParser_T110 arg1Of capacity,the
EnjuParser_R11 EnjuParser_T13 EnjuParser_T12 arg1Of mutations,BRAF
EnjuParser_R110 EnjuParser_T113 EnjuParser_T111 arg1Of capacity,ATP
EnjuParser_R111 EnjuParser_T113 EnjuParser_T112 arg1Of capacity,binding
EnjuParser_R112 EnjuParser_T113 EnjuParser_T114 arg1Of capacity,of
EnjuParser_R113 EnjuParser_T115 EnjuParser_T114 arg2Of MAP2K5,of
EnjuParser_R114 EnjuParser_T117 EnjuParser_T116 arg1Of vitro,in
EnjuParser_R115 EnjuParser_T109 EnjuParser_T117 arg1Of compromise,vitro
EnjuParser_R116 EnjuParser_T109 EnjuParser_T118 arg1Of compromise,and
EnjuParser_R117 EnjuParser_T119 EnjuParser_T118 arg2Of inhibit,and
EnjuParser_R118 EnjuParser_T107 EnjuParser_T119 arg1Of vemurafenib,inhibit
EnjuParser_R119 EnjuParser_T122 EnjuParser_T119 arg2Of activity,inhibit
EnjuParser_R12 EnjuParser_T13 EnjuParser_T14 arg1Of mutations,contribute
EnjuParser_R120 EnjuParser_T122 EnjuParser_T120 arg1Of activity,its
EnjuParser_R121 EnjuParser_T122 EnjuParser_T121 arg1Of activity,kinase
EnjuParser_R122 EnjuParser_T122 EnjuParser_T123 arg1Of activity,in
EnjuParser_R123 EnjuParser_T124 EnjuParser_T123 arg2Of cells,in
EnjuParser_R124 EnjuParser_T152 EnjuParser_T125 arg1Of and,Together
EnjuParser_R125 EnjuParser_T152 EnjuParser_T126 arg1Of and,","
EnjuParser_R126 EnjuParser_T131 EnjuParser_T127 arg1Of methods,our
EnjuParser_R127 EnjuParser_T131 EnjuParser_T128 arg2Of methods,targeted
EnjuParser_R128 EnjuParser_T131 EnjuParser_T129 arg1Of methods,quantitative
EnjuParser_R129 EnjuParser_T131 EnjuParser_T130 arg1Of methods,proteomic
EnjuParser_R13 EnjuParser_T14 EnjuParser_T15 arg1Of contribute,to
EnjuParser_R130 EnjuParser_T131 EnjuParser_T132 arg1Of methods,revealed
EnjuParser_R131 EnjuParser_T134 EnjuParser_T132 arg2Of changes,revealed
EnjuParser_R132 EnjuParser_T134 EnjuParser_T133 arg1Of changes,profound
EnjuParser_R133 EnjuParser_T134 EnjuParser_T135 arg1Of changes,in
EnjuParser_R134 EnjuParser_T137 EnjuParser_T135 arg2Of levels,in
EnjuParser_R135 EnjuParser_T137 EnjuParser_T136 arg1Of levels,expression
EnjuParser_R136 EnjuParser_T137 EnjuParser_T138 arg1Of levels,of
EnjuParser_R137 EnjuParser_T140 EnjuParser_T138 arg2Of proteins,of
EnjuParser_R138 EnjuParser_T140 EnjuParser_T139 arg1Of proteins,kinase
EnjuParser_R139 EnjuParser_T137 EnjuParser_T141 arg1Of levels,in
EnjuParser_R14 EnjuParser_T17 EnjuParser_T15 arg2Of development,to
EnjuParser_R140 EnjuParser_T144 EnjuParser_T141 arg2Of cells,in
EnjuParser_R141 EnjuParser_T144 EnjuParser_T142 arg2Of cells,cultured
EnjuParser_R142 EnjuParser_T144 EnjuParser_T143 arg1Of cells,melanoma
EnjuParser_R143 EnjuParser_T132 EnjuParser_T145 arg1Of revealed,upon
EnjuParser_R144 EnjuParser_T146 EnjuParser_T145 arg2Of treatment,upon
EnjuParser_R145 EnjuParser_T146 EnjuParser_T147 arg1Of treatment,with
EnjuParser_R146 EnjuParser_T151 EnjuParser_T147 arg2Of inhibitors,with
EnjuParser_R147 EnjuParser_T149 EnjuParser_T148 arg1Of used,clinically
EnjuParser_R148 EnjuParser_T151 EnjuParser_T149 arg1Of inhibitors,used
EnjuParser_R149 EnjuParser_T151 EnjuParser_T150 arg1Of inhibitors,BRAF
EnjuParser_R15 EnjuParser_T17 EnjuParser_T16 arg1Of development,the
EnjuParser_R150 EnjuParser_T132 EnjuParser_T152 arg1Of revealed,and
EnjuParser_R151 EnjuParser_T153 EnjuParser_T152 arg2Of led,and
EnjuParser_R152 EnjuParser_T131 EnjuParser_T153 arg1Of methods,led
EnjuParser_R153 EnjuParser_T153 EnjuParser_T154 arg1Of led,to
EnjuParser_R154 EnjuParser_T156 EnjuParser_T154 arg2Of discovery,to
EnjuParser_R155 EnjuParser_T156 EnjuParser_T155 arg1Of discovery,the
EnjuParser_R156 EnjuParser_T156 EnjuParser_T157 arg1Of discovery,of
EnjuParser_R157 EnjuParser_T161 EnjuParser_T157 arg2Of kinases,of
EnjuParser_R158 EnjuParser_T161 EnjuParser_T158 arg1Of kinases,novel
EnjuParser_R159 EnjuParser_T161 EnjuParser_T159 arg1Of kinases,putative
EnjuParser_R16 EnjuParser_T17 EnjuParser_T18 arg1Of development,of
EnjuParser_R160 EnjuParser_T161 EnjuParser_T160 arg1Of kinases,target
EnjuParser_R161 EnjuParser_T161 EnjuParser_T162 arg1Of kinases,for
EnjuParser_R162 EnjuParser_T164 EnjuParser_T162 arg2Of inhibitors,for
EnjuParser_R163 EnjuParser_T164 EnjuParser_T163 arg1Of inhibitors,these
EnjuParser_R17 EnjuParser_T20 EnjuParser_T18 arg2Of number,of
EnjuParser_R18 EnjuParser_T20 EnjuParser_T19 arg1Of number,a
EnjuParser_R19 EnjuParser_T20 EnjuParser_T21 arg1Of number,of
EnjuParser_R2 EnjuParser_T6 EnjuParser_T2 arg2Of Perturbed,of
EnjuParser_R20 EnjuParser_T22 EnjuParser_T21 arg2Of cancers,of
EnjuParser_R21 EnjuParser_T24 EnjuParser_T23 arg1Of and,","
EnjuParser_R22 EnjuParser_T14 EnjuParser_T24 arg1Of contribute,and
EnjuParser_R23 EnjuParser_T30 EnjuParser_T24 arg2Of approved,and
EnjuParser_R24 EnjuParser_T27 EnjuParser_T25 arg1Of inhibitors,small-molecule
EnjuParser_R25 EnjuParser_T27 EnjuParser_T26 arg1Of inhibitors,BRAF
EnjuParser_R26 EnjuParser_T27 EnjuParser_T28 arg1Of inhibitors,have
EnjuParser_R27 EnjuParser_T30 EnjuParser_T28 arg2Of approved,have
EnjuParser_R28 EnjuParser_T27 EnjuParser_T29 arg1Of inhibitors,been
EnjuParser_R29 EnjuParser_T30 EnjuParser_T29 arg2Of approved,been
EnjuParser_R3 EnjuParser_T6 EnjuParser_T3 arg1Of Perturbed,the
EnjuParser_R30 EnjuParser_T34 EnjuParser_T30 arg1Of and,approved
EnjuParser_R31 EnjuParser_T27 EnjuParser_T30 arg2Of inhibitors,approved
EnjuParser_R32 EnjuParser_T34 EnjuParser_T31 arg2Of and,by
EnjuParser_R33 EnjuParser_T34 EnjuParser_T32 arg1Of and,the
EnjuParser_R34 EnjuParser_T33 EnjuParser_T34 arg1Of Food,and
EnjuParser_R35 EnjuParser_T36 EnjuParser_T34 arg2Of Administration,and
EnjuParser_R36 EnjuParser_T36 EnjuParser_T35 arg1Of Administration,Drug
EnjuParser_R37 EnjuParser_T34 EnjuParser_T37 arg1Of and,(
EnjuParser_R38 EnjuParser_T38 EnjuParser_T37 arg2Of FDA,(
EnjuParser_R39 EnjuParser_T39 EnjuParser_T37 arg3Of ),(
EnjuParser_R4 EnjuParser_T6 EnjuParser_T4 arg1Of Perturbed,Human
EnjuParser_R40 EnjuParser_T34 EnjuParser_T40 arg1Of and,for
EnjuParser_R41 EnjuParser_T42 EnjuParser_T40 arg2Of therapy,for
EnjuParser_R42 EnjuParser_T42 EnjuParser_T41 arg1Of therapy,anticancer
EnjuParser_R43 EnjuParser_T48 EnjuParser_T43 arg1Of employed,In
EnjuParser_R44 EnjuParser_T45 EnjuParser_T43 arg2Of study,In
EnjuParser_R45 EnjuParser_T45 EnjuParser_T44 arg1Of study,this
EnjuParser_R46 EnjuParser_T48 EnjuParser_T46 arg1Of employed,","
EnjuParser_R47 EnjuParser_T47 EnjuParser_T48 arg1Of we,employed
EnjuParser_R48 EnjuParser_T53 EnjuParser_T48 arg2Of approaches,employed
EnjuParser_R49 EnjuParser_T53 EnjuParser_T49 arg1Of approaches,two
EnjuParser_R5 EnjuParser_T6 EnjuParser_T5 arg1Of Perturbed,Kinome
EnjuParser_R50 EnjuParser_T53 EnjuParser_T50 arg2Of approaches,targeted
EnjuParser_R51 EnjuParser_T53 EnjuParser_T51 arg1Of approaches,quantitative
EnjuParser_R52 EnjuParser_T53 EnjuParser_T52 arg1Of approaches,proteomics
EnjuParser_R53 EnjuParser_T53 EnjuParser_T54 arg1Of approaches,for
EnjuParser_R54 EnjuParser_T55 EnjuParser_T54 arg2Of monitoring,for
EnjuParser_R55 EnjuParser_T58 EnjuParser_T55 arg2Of alterations,monitoring
EnjuParser_R56 EnjuParser_T55 EnjuParser_T56 arg1Of monitoring,separately
EnjuParser_R57 EnjuParser_T58 EnjuParser_T57 arg1Of alterations,the
EnjuParser_R58 EnjuParser_T58 EnjuParser_T59 arg1Of alterations,in
EnjuParser_R59 EnjuParser_T62 EnjuParser_T59 arg2Of and,in
EnjuParser_R6 EnjuParser_T1 EnjuParser_T7 arg1Of Interrogation,by
EnjuParser_R60 EnjuParser_T61 EnjuParser_T60 arg1Of expression,protein
EnjuParser_R61 EnjuParser_T61 EnjuParser_T62 arg1Of expression,and
EnjuParser_R62 EnjuParser_T65 EnjuParser_T62 arg2Of affinities,and
EnjuParser_R63 EnjuParser_T65 EnjuParser_T63 arg1Of affinities,ATP
EnjuParser_R64 EnjuParser_T65 EnjuParser_T64 arg1Of affinities,binding
EnjuParser_R65 EnjuParser_T58 EnjuParser_T66 arg1Of alterations,of
EnjuParser_R66 EnjuParser_T67 EnjuParser_T66 arg2Of kinases,of
EnjuParser_R67 EnjuParser_T67 EnjuParser_T68 arg1Of kinases,in
EnjuParser_R68 EnjuParser_T72 EnjuParser_T68 arg2Of cells,in
EnjuParser_R69 EnjuParser_T72 EnjuParser_T69 arg2Of cells,cultured
EnjuParser_R7 EnjuParser_T10 EnjuParser_T7 arg2Of Inhibitors,by
EnjuParser_R70 EnjuParser_T72 EnjuParser_T70 arg1Of cells,human
EnjuParser_R71 EnjuParser_T72 EnjuParser_T71 arg1Of cells,melanoma
EnjuParser_R72 EnjuParser_T79 EnjuParser_T73 arg1Of inhibitors,elicited
EnjuParser_R73 EnjuParser_T72 EnjuParser_T73 arg2Of cells,elicited
EnjuParser_R74 EnjuParser_T79 EnjuParser_T74 arg2Of inhibitors,by
EnjuParser_R75 EnjuParser_T79 EnjuParser_T75 arg1Of inhibitors,two
EnjuParser_R76 EnjuParser_T79 EnjuParser_T76 arg1Of inhibitors,FDA-approved
EnjuParser_R77 EnjuParser_T79 EnjuParser_T77 arg1Of inhibitors,small-molecule
EnjuParser_R78 EnjuParser_T79 EnjuParser_T78 arg1Of inhibitors,BRAF
EnjuParser_R79 EnjuParser_T79 EnjuParser_T80 arg1Of inhibitors,","
EnjuParser_R8 EnjuParser_T10 EnjuParser_T8 arg1Of Inhibitors,Two
EnjuParser_R80 EnjuParser_T82 EnjuParser_T80 arg2Of and,","
EnjuParser_R81 EnjuParser_T81 EnjuParser_T82 arg1Of dabrafenib,and
EnjuParser_R82 EnjuParser_T83 EnjuParser_T82 arg2Of vemurafenib,and
EnjuParser_R83 EnjuParser_T85 EnjuParser_T84 arg1Of results,Our
EnjuParser_R84 EnjuParser_T85 EnjuParser_T86 arg1Of results,showed
EnjuParser_R85 EnjuParser_T93 EnjuParser_T86 arg2Of led,showed
EnjuParser_R86 EnjuParser_T93 EnjuParser_T87 arg1Of led,that
EnjuParser_R87 EnjuParser_T88 EnjuParser_T89 arg1Of treatment,with
EnjuParser_R88 EnjuParser_T92 EnjuParser_T89 arg2Of inhibitors,with
EnjuParser_R89 EnjuParser_T92 EnjuParser_T90 arg1Of inhibitors,the
EnjuParser_R9 EnjuParser_T10 EnjuParser_T9 arg1Of Inhibitors,BRAF
EnjuParser_R90 EnjuParser_T92 EnjuParser_T91 arg1Of inhibitors,two
EnjuParser_R91 EnjuParser_T88 EnjuParser_T93 arg1Of treatment,led
EnjuParser_R92 EnjuParser_T93 EnjuParser_T94 arg1Of led,to
EnjuParser_R93 EnjuParser_T97 EnjuParser_T94 arg2Of reprograming,to
EnjuParser_R94 EnjuParser_T96 EnjuParser_T95 arg1Of different,markedly
EnjuParser_R95 EnjuParser_T97 EnjuParser_T96 arg1Of reprograming,different
EnjuParser_R96 EnjuParser_T97 EnjuParser_T98 arg1Of reprograming,of
EnjuParser_R97 EnjuParser_T101 EnjuParser_T98 arg2Of kinome,of
EnjuParser_R98 EnjuParser_T101 EnjuParser_T99 arg1Of kinome,the
EnjuParser_R99 EnjuParser_T101 EnjuParser_T100 arg1Of kinome,human